Диссертация (1139542), страница 55
Текст из файла (страница 55)
‒ V. 115. ‒ P. 997-1003.Maestrelli P., Ferrazzoni S., Visentin A., Marian E., Dal Borgo D., Accordino R., Fabbri L.M. Measurement of exhaled nitric oxide in healthy adults // Sarcoidosis Vasc Diffuse LungDis. ‒ 2007. ‒ V. 24, № 1. ‒ P. 65-69.Mak J. C., Leung H. C., Ho S. P., Law B. K., Lam W. K., Tsang K. W., Ip M. S., ChanYeung M. Systemic oxidative and antioxidative status in Chinese patients with asthma // JAllergy Clin Immunol. ‒ 2004.
‒ V. 114, № 2. ‒ P. 260-264.305359360361362363364365366367368369370371372373374375376377378Marcal L. E., Rehder J., Newburger P. E., Condino-Neto A. Superoxide release and cellulargluthatione peroxidase activity in leukocytes from children with persistent asthma // Braz JMed Biol Res. ‒ 2004. ‒ V. 37, № 11.
‒ P. 1607-1613.McFadden E. R., Lenner K. A., Strohl K. P. Postexertional airway rewarming and thermallyinduced asthma. New insights into pathophysiology and possible pathogenesis. // J ClinInvest. - 1986. ‒ V.78, №1. - P. 18-25.Michils A., Baldassarre S., Van Muylem A. Exhaled nitric oxide and asthma control: alongitudinal study in unselected patients // Eur Respir J. ‒ 2008. ‒ V. 31, № 3. ‒ P. 539-46.Miller M. R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., al. e.Standardisation of spirometry. // Eur Respir J ‒2005. № 26.
‒ P. 153-161.Moeller A., Carlsen K.-H., Sly P. D., al. E. Monitoring asthma in childhood: lung function,bronchial responsiveness and inflammation. // Eur Respir Rev. ‒ 2015. ‒ V. 24, № 136. ‒ P.204-215.Monteseirín J. Neutrophils and asthma. // J Investig Allergol Clin Immunol.
‒ 2009. ‒ V.19, № 5. ‒ P. 340-354.Monteseirin J., Camacho M. J., Bonilla I., De la Calle A., Guardia P., Sobrino F.Respiratory burst in neutrophils from asthmatic patients. // J Asthma. ‒ 2002. ‒ V. 39, № 7.‒ P. 619-624.Morrison J. F., Pearson S. B. The effect of the circadian rhythm of vagal activity onbronchomotor tone in asthma. // Br. J. Clin. Pharmacol.
‒ 1989. ‒ V. 28, № 5. ‒ P. 545-549.Morrison J. F., Pearson S. B., al. e. Parasympathetic nervous system in nocturnal asthma. //Br. Med. J. (Clin. Res. Ed.). ‒ 1988. ‒ V. 66, № 3-4. ‒ P. 1427-1429.Moschino L., Zanconato S., Bozzetto S., Baraldi E., Carraro S. Childhood asthmabiomarkers: present knowledge and future steps. // Paediatr Respir Rev. ‒2015.10.1016/j.prrv.2015.05.001 № 5. ‒ P. 1526-1542.Mossberg B. Postural mechanisms in asthma: importance for nocturnal symptoms. // Lung ‒1990. ‒ V. 168. ‒ P.
595-598.Mukhopadhyay J., Bates R., al. e. Changes in vagal tone with posture in asthma are relatedto changes in ventilatory pattern. // Respiratory Medicine. ‒ 2007. ‒ V. 101, № 5. ‒ P. 10011006.Müller U., Hari Y., Berchtold E. Premedication with antihistamines may enhance efficacyof specific-allergen immunotherapy. // J Allergy Clin Immunol.
‒ 2001. ‒ V. 107, № 1. ‒ P.81-86.Mulrennan S. A., Redington A. E. Nitric oxide synthase inhibition: therapeutic potential inasthma // Treat Respir Med. ‒ 2004. ‒ V. 3, № 2. ‒ P. 79-88.Muñoz X., Bustamante V., Lopez-Campos J. L., Cruz M. J., Barreiro E. Usefulness ofnoninvasive methods for the study of bronchial inflammation in the control of patients withasthma. // Arch Allergy Immunol. / 2015. ‒ C. 1-12.Murdoch J. R., Lloyd C.
M. Chronic inflammation and asthma. // Mutat Res. ‒ 2010. ‒ V.690, № 1-2. ‒ P. 24-39.Nadeem A., Chhabra S. K., Masood A., Raj H. G. Increased oxidative stress and alteredlevels of antioxidants in asthma // J Allergy Clin Immunol. ‒ 2003. ‒ V. 111, № 1. ‒ P. 7278.Nadeem A., Masood A., Siddiqui N.
Oxidant--antioxidant imbalance in asthma: scientificevidence, epidemiological data and possible therapeutic options // Ther Adv Respir Dis. ‒2008. ‒ V. 2, № 4. ‒ P. 215-235.Nadeem A., Siddiqui N., Alharbi N. O., Alharbi M. M. Airway and systemic oxidantantioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lunginto blood.
// Pulmonary Pharmacology and Therapeutics. - 2014. ‒ P. 31-40.Nagata M., Nakagome K. Allergen Immunotherapy in Asthma: Current Status and FuturePerspectives. // Allergology International ‒2010. № 1. ‒ P. 15-19.306379380381382383384385386387388389390391392393394395396397398Nagata M., Saito K., Kikuchi I., al. e. Immunotherapy attenuates eosinophil transendothelialmigration induced by the supernatants of antigen-stimulated mononuclear cells from atopicasthmatics. // Int Arch Allergy Immunol ‒2004. ‒ V. 134, № (Suppl 1).
‒ P. 21-24.Nakagome K., Matsushita S., Nagata M. Neutrophilic inflammation in severe asthma. // IntArch Allergy Immunol. ‒ 2012. ‒ V. 158, № Suppl 1. ‒ P. 96-102.Nakagome K., Nagata M. Pathogenesis of airway inflammation in bronchial asthma. //Auris Nasus Larynx. ‒ 2011. ‒ V.
38, № 5. ‒ P. 555-563.Nathan C., Xie Q. W. Nitric oxide synthase: roles, tools, and controls. // Cell ‒1994. ‒ V.78, №6, – P. 915-908.Nathan R. A., Sorkness C. A., Kosinski M., Schatz M., li J. T., Marcus H., et al.Development of the asthma control test: a survey for assessing control. // J Allergy ClinImmunol. ‒ 2004. ‒ V. 113, № 1. ‒ P. 51-65.Navratil M., Plavec D., Dodig S., et al. Markers of systemic and lung inflammation inchildhood asthma // J Asthma. ‒ 2009.
‒ V. 46, № 8. ‒ P. 822-828.Nazir Z., Razaq S., Mir S., al. E. Revisiting the accuracy of peak flow meters: a doubleblind study using formal methods of agreement. // Respir Med. . ‒ 2005. ‒ V. 99, № 5. ‒ P.592-595.Netzer N. C., Küpper T., Voss H. W., Eliasson A. H. The actual role of sodiumcromoglycate in the treatment of asthma--a critical review. // Sleep Breath. ‒ 2012.
‒ V. 16,№ 4. ‒ P. 1027-1032.Nicolaou N. C., Lowe L. A., Murray C. S., Woodcock A., Simpson A., Custovic A. Exhaledbreath condensate pH and childhood asthma: unselected birth cohort study // Am J RespirCrit Care Med. ‒ 2006. ‒ V. 174, № 3. ‒ P. 254-259.Nielsen L., Johnsen C. R., Mosbech H., Poulsen L. K., Malling H. J.
Antihistaminepremedication in specific cluster immunotherapy: a double-blind, placebo-controlled study.// J Allergy Clin Immunol. ‒ 1996. ‒ V. 97, № 6. ‒ P. 1207-1213.Nockher W. A., Renz H. Neurotrophins and asthma: Novel insight into neuroimmuneinteraction. // Journal of Allergy and Clinical Immunology.
‒ 2006. ‒ V. 117, № 1. ‒ P. 6771.Nuijsink M., Hop W. C., Sterk P. J., Duiverman E. J., de Jongste J. C. Long-term asthmatreatment guided by airway hyperresponsiveness in children: a randomised controlled trial.// Eur Respir J. ‒ 2007. ‒ V. 30, № 3. ‒ P. 457-466.Ojoo J. C., Mulrennan S. A., Kastelik J. A., Morice A.
H., Redington A. E. Exhaled breathcondensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis // Thorax. ‒2005. ‒ V. 60, № 1. ‒ P. 22-6.Olin J. T., Wechsler M. E. Asthma: pathogenesis and novel drugs for treatment. // BMJ. ‒2014. ‒ V. 24, № 349. ‒ P. g5517.Olopade C. O., Zakkar M., Swedler W. I., Rubinstein I. Exhaled pentane levels in acuteasthma. // Chest. ‒ 1997.
‒ V. 111. ‒ P. 862-865.Oñatibia-Astibia A., Martínez-Pinilla E., Franco R. The potential of methylxanthine-basedtherapies in pediatric respiratory tract diseases. // Respir Med. - 2016. ‒ P. 1-9.Ozaras R., Tahan V., Turkmen S., Talay F., Besirli K., Aydin S., Uzun H., Cetinkaya A.Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment ofasthma with inhaled steroid and beta2-agonist // Respirology. ‒ 2000. ‒ V. 5, № 3. ‒ P. 289292.Palmer R.
M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biologicalactivity of endothelium-derived relaxing factor. // Nature. ‒ 1987. ‒ V. 327. ‒ P. 524-526.Papadopoulos N. G., Arakawa H., Carlsen K.-H., Custovic A., Gern J., Lemanske R. F., al.E. International consensus on (ICON) pediatric asthma.
// Allergy. ‒ 2012. ‒ V. 67. - № 8. ‒С. 976-997.Papaioannou A. I., Kostikas K., Zervas E., al. E. Control of asthma in real life: still avaluable goal? // Eur Respir Rev. ‒ 2015 ‒V. 24, № 136. ‒ P. 361-369.307399400401402403404405406407408409410411412413414415416417418Papakosta D., Latsios D., Manika K., Porpodis K. Asthma control test is correlated to FEV1and nitric oxide in Greek asthmatic patients: influence of treatment. // J Asthma. ‒ 2011. ‒V.
48, № 9. ‒ P. 901-906.Paredi P., Kharitonov S. A., Barnes P. J. Elevation of exhaled ethane concentration inasthma // Am J Respir Crit Care Med. ‒ 2000. ‒ V. 162, № 4 Pt 1. ‒ P. 1450-1454.Park H. W. The role of tiotropium in the management of asthma. // Asia Pac Allergy. . ‒2012. ‒ V. 2, № 2. ‒ P. 109-114.Pelaia G., Vatrella A., Busceti M. T., al.
E. Cellular Mechanisms Underlying Eosinophilicand Neutrophilic Airway Inflammation in Asthma. // Mediators Inflamm. ‒ 2015. –P.879783Pelikan Z. Diagnostic value of nasal allergen challenge combined with radiography andultrasonography in chronic maxillary sinus disease. // Arch Otolaryngol Head Neck Surg. ‒2009 ‒V. 135, № 12.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
